BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 2112132)

  • 21. Which antidepressant?
    Benaim S
    Br J Clin Pract; 1990 May; 44(5):196-200. PubMed ID: 2390444
    [No Abstract]   [Full Text] [Related]  

  • 22. Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients.
    Austin LS; Arana GW; Melvin JA
    J Clin Psychiatry; 1990 Aug; 51(8):344-5. PubMed ID: 2380160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacological treatment of depression].
    Castro P; Wilmotte J
    Rev Med Brux; 1994; 15(5):306-10. PubMed ID: 7984847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biologic markers and prediction of response to treatment in depression].
    Uytdenhoef P; Linkowski P; Mendlewicz J
    Acta Psychiatr Belg; 1982; 82(3):229-42. PubMed ID: 6187184
    [No Abstract]   [Full Text] [Related]  

  • 26. Endogenous depression: biochemical determinants and drug treatment.
    Hollister LE
    Drug Ther; 1982; ():81-98. PubMed ID: 7049653
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy refractory depression].
    Hatzinger M; Holsboer-Trachsler E
    Wien Med Wochenschr; 1999; 149(18):511-4. PubMed ID: 10637955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The treatment of depression: update 1984.
    Enowitch BI
    Conn Med; 1984 Nov; 48(11):703-6. PubMed ID: 6391806
    [No Abstract]   [Full Text] [Related]  

  • 29. Managing resistant depression. When patients do not respond to therapy.
    Warneke L
    Can Fam Physician; 1993 Apr; 39():843-50. PubMed ID: 8495142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP; Herbstein J; Damlouji N
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression.
    Inoue T; Tsuchiya K; Miura J; Sakakibara S; Denda K; Kasahara T; Koyama T
    Biol Psychiatry; 1996 Jul; 40(2):151-3. PubMed ID: 8793048
    [No Abstract]   [Full Text] [Related]  

  • 32. Depression.
    Davis D; Chapel JL
    Am Fam Physician; 1982 Dec; 26(6):156-62. PubMed ID: 7148639
    [No Abstract]   [Full Text] [Related]  

  • 33. The assessment and treatment of refractory depression.
    Phillips KA; Nierenberg AA
    J Clin Psychiatry; 1994 Feb; 55 Suppl():20-6. PubMed ID: 8077165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
    Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
    Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating antidepressant nonresponders with augmentation strategies: an overview.
    Thase ME; Howland RH; Friedman ES
    J Clin Psychiatry; 1998; 59 Suppl 5():5-12; discussion 13-5. PubMed ID: 9635543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and treatment of depression in the cancer patient.
    Massie MJ; Holland JC
    J Clin Psychiatry; 1984 Mar; 45(3 Pt 2):25-9. PubMed ID: 6698949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacotherapy of major depressive syndrome. Part 2: Prophylaxis of recurrent depressive illness.
    Shopsin B; Waters B
    Psychosomatics; 1980 Aug; 21(8):649-51, 655-6. PubMed ID: 7208770
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of monoamine oxidase inhibitors in depression treatment guidelines.
    Thase ME
    J Clin Psychiatry; 2012; 73 Suppl 1():10-6. PubMed ID: 22951237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discussion: a fresh look at monoamine oxidase inhibitors for depression.
    Cohen LJ; Sclar DA; Culpepper L; Flockhart DA; Hirschfeld RM; Thase ME; VanDenBerg CM
    J Clin Psychiatry; 2012; 73 Suppl 1():42-5. PubMed ID: 22951242
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.